Dow Down 0.17% Nasdaq Down 0.28%

AbbVie Inc. (ABBV)

-NYSE
57.76 Down 0.76(1.30%) 4:00PM EDT
|After Hours : 58.56 Up 0.80 (1.38%) 6:18PM EDT - Nasdaq Real Time Price
Prev Close:58.52
Open:58.24
Bid:56.96 x 200
Ask:57.78 x 100
1y Target Est:67.38
Beta:1.928
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:57.73 - 58.81
52wk Range:44.32 - 60.02
Volume:8,599,025
Avg Vol (3m):12,163,900
Market Cap:91.94B
P/E (ttm):22.39
EPS (ttm):2.58
Div & Yield:1.68 (3.20%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVDown 1.30%91.94B
MRKDown 0.22%171.00B
NVSUp 0.61%228.38B
PFEDown 0.67%187.50B

Key Statistics

Forward P/E (1 yr):14.81
P/S (ttm):4.84
Ex-Dividend Date:11-Jul-14

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback